CELC
Price
$9.32
Change
-$0.79 (-7.81%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
344.93M
47 days until earnings call
CLDX
Price
$16.84
Change
-$1.31 (-7.22%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
1.12B
29 days until earnings call
Ad is loading...

CELC vs CLDX

Header iconCELC vs CLDX Comparison
Open Charts CELC vs CLDXBanner chart's image
Celcuity
Price$9.32
Change-$0.79 (-7.81%)
Volume$10.2K
Capitalization344.93M
Celldex Therapeutics
Price$16.84
Change-$1.31 (-7.22%)
Volume$4.86K
Capitalization1.12B
CELC vs CLDX Comparison Chart
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. CLDX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a StrongBuy and CLDX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (CELC: $10.11 vs. CLDX: $18.15)
Brand notoriety: CELC and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 206% vs. CLDX: 165%
Market capitalization -- CELC: $344.93M vs. CLDX: $1.12B
CELC [@Biotechnology] is valued at $344.93M. CLDX’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while CLDX’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 5 bearish.
  • CLDX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CELC and CLDX are a good buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а -6.73% price change this week, while CLDX (@Biotechnology) price change was -12.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

CELC is expected to report earnings on May 19, 2025.

CLDX is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.12B) has a higher market cap than CELC($345M). CELC YTD gains are higher at: -22.765 vs. CLDX (-28.176). CELC has higher annual earnings (EBITDA): -85.45M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. CELC (264M). CLDX has less debt than CELC: CLDX (3.81M) vs CELC (97.2M). CLDX has higher revenues than CELC: CLDX (7.02M) vs CELC (0).
CELCCLDXCELC / CLDX
Capitalization345M1.12B31%
EBITDA-85.45M-191.9M45%
Gain YTD-22.765-28.17681%
P/E RatioN/AN/A-
Revenue07.02M-
Total Cash264M725M36%
Total Debt97.2M3.81M2,549%
FUNDAMENTALS RATINGS
CELC vs CLDX: Fundamental Ratings
CELC
CLDX
OUTLOOK RATING
1..100
1672
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
8562
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
6485
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (39) in the Miscellaneous Commercial Services industry is in the same range as CLDX (58) in the Biotechnology industry. This means that CELC’s stock grew similarly to CLDX’s over the last 12 months.

CLDX's Profit vs Risk Rating (62) in the Biotechnology industry is in the same range as CELC (85) in the Miscellaneous Commercial Services industry. This means that CLDX’s stock grew similarly to CELC’s over the last 12 months.

CLDX's SMR Rating (96) in the Biotechnology industry is in the same range as CELC (98) in the Miscellaneous Commercial Services industry. This means that CLDX’s stock grew similarly to CELC’s over the last 12 months.

CELC's Price Growth Rating (64) in the Miscellaneous Commercial Services industry is in the same range as CLDX (85) in the Biotechnology industry. This means that CELC’s stock grew similarly to CLDX’s over the last 12 months.

CELC's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as CLDX (100) in the Biotechnology industry. This means that CELC’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCCLDX
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 21 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 7 days ago
88%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EDIRX10.45N/A
N/A
Eaton Vance Global Income Builder R
UIIFX27.81N/A
N/A
Victory International Institutional
TRZLX39.66N/A
N/A
T. Rowe Price US Large-Cap Core Z
LPEIX6.58N/A
N/A
ALPS Global Opportunity I
SMFAX28.15-0.01
-0.04%
American Beacon Stephens Mid-Cap Gr A

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-1.27%
ABOS - CELC
43%
Loosely correlated
-7.56%
PRME - CELC
43%
Loosely correlated
N/A
CLDX - CELC
41%
Loosely correlated
-8.93%
CRNX - CELC
41%
Loosely correlated
-3.43%
VTGN - CELC
40%
Loosely correlated
-3.47%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with DNLI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-8.93%
DNLI - CLDX
47%
Loosely correlated
-8.02%
KYMR - CLDX
44%
Loosely correlated
-7.60%
BEAM - CLDX
43%
Loosely correlated
-12.07%
AXON - CLDX
43%
Loosely correlated
-1.68%
ATXS - CLDX
42%
Loosely correlated
-6.32%
More